Literature DB >> 3493449

Localization of binding sites for calcitonin gene-related peptide in rat brain by in vitro autoradiography.

P M Sexton, J S McKenzie, R T Mason, J M Moseley, T J Martin, F A Mendelsohn.   

Abstract

The distribution of binding sites for calcitonin gene-related peptide (CGRP) in rat brain were studied using in vitro autoradiography. In a radioreceptor assay using [125I]human calcitonin gene-related peptide as the radioligand, with cerebellar cortical membranes, rat calcitonin gene-related peptide had a binding affinity constant of 1.16 +/- 0.23 X 10(10) M-1 and a site concentration of 43.4 +/- 3.4 fmol/mg protein. In this system, human calcitonin gene-related peptide had a binding affinity constant of 3.9 +/- 0.7 X 10(9) M-1 whereas salmon calcitonin was very weak with a binding affinity constant of only 6.8 +/- 4.0 X 10(5) M-1. CGRP binding localized by in vitro autoradiography, using [125I]rat calcitonin gene-related peptide, had a characteristic distinct distribution in the rat brain. There were high concentrations of binding found over the accumbens nucleus, the organum vasculosum of the lamina terminalis, ventral caudate putamen, median eminence, the arcuate nucleus, lateral amygdaloid nucleus and lateral mammillary nucleus, the superior and inferior colliculi, pontine nuclei, molecular and Purkinje cell layers of the cerebellar cortex, the nucleus of the solitary tract, the inferior olivary nuclei, hypoglossal complex and the vestibular and cochlear nuclei. The distribution of these binding sites suggests multiple roles for CGRP in the central nervous system including auditory, visual, gustatory and somatosensory processing, and in neuroendocrine control.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3493449     DOI: 10.1016/0306-4522(86)90137-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  12 in total

1.  Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures.

Authors:  Kelly S Sink; David L Walker; Yong Yang; Michael Davis
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

Review 2.  Central nervous system binding sites for calcitonin and calcitonin gene-related peptide.

Authors:  P M Sexton
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

Review 3.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

4.  Reversible calcitonin binding to solubilized sheep brain binding sites.

Authors:  P M Sexton; H G Schneider; C S D'Santos; F A Mendelsohn; B E Kemp; J M Moseley; T J Martin; D M Findlay
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

5.  Role of central calcitonin gene-related peptide (CGRP) in locomotor and anxiety- and depression-like behaviors in two mouse strains exhibiting a CGRP-dependent difference in thermal pain sensitivity.

Authors:  Ara Schorscher-Petcu; Jean-Sébastien Austin; Jeffrey S Mogil; Rémi Quirion
Journal:  J Mol Neurosci       Date:  2009-04-18       Impact factor: 3.444

6.  Effect of CGRP antagonist, alpha-CGRP 8-37, on acid secretion in the dog.

Authors:  D C Lawson; C R Mantyh; T N Pappas
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

7.  Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines.

Authors:  Tejal Choksi; Debbie L Hay; Stephen Legon; David R Poyner; Stefanie Hagner; Stephen R Bloom; David M Smith
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

Review 8.  Is calcitonin gene-related peptide a modulator of menopausal vasomotor symptoms?

Authors:  Maria Alice Oliveira; William Gustavo Lima; Dante Alighieri Schettini; Cristiane Queixa Tilelli; Valéria Ernestânia Chaves
Journal:  Endocrine       Date:  2018-10-10       Impact factor: 3.633

9.  A second trigeminal CGRP receptor: function and expression of the AMY1 receptor.

Authors:  Christopher S Walker; Sajedeh Eftekhari; Rebekah L Bower; Andrea Wilderman; Paul A Insel; Lars Edvinsson; Henry J Waldvogel; Muhammad A Jamaluddin; Andrew F Russo; Debbie L Hay
Journal:  Ann Clin Transl Neurol       Date:  2015-04-01       Impact factor: 4.511

10.  The effect of intracerebroventricular injection of CGRP on pain behavioral responses and monoamines concentrations in the periaqueductal gray area in rat.

Authors:  Kaveh Rahimi; Javad Sajedianfard; Ali Akbar Owji
Journal:  Iran J Basic Med Sci       Date:  2018-04       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.